Journal
LABMEDICINE
Volume 39, Issue 6, Pages 361-364Publisher
AMER SOC CLINICAL PATHOLOGY
DOI: 10.1309/B14F0BXK93YQ9QV5
Keywords
-
Categories
Ask authors/readers for more resources
Pulmonary embolism (PE) is a leading cause of mortality in North America. Prompt recognition and treatment of PE with anticoagulant therapy reduces the risk of mortality from 30% to 1.5%. Unfortunately, timely diagnosis of PE can be difficult because the clinical features of PE, such as chest pain and rapid heart rate, are not unique to PE. Although clinical assessment alone cannot confirm or exclude PE, it can be used to stratify patients according to their likelihood of having PE before diagnostic tests are performed (ie, pretest probability). This paper will review the role of clinical assessment in the diagnosis of PE, provide an overview of validated clinical prediction rules for PE, and discuss the reproducibility of clinical pretest probability assessment in suspected PE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available